Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications. Vainer G, Huang L, Emancipator K, Nuti S, et al. PLoS One 2023;18:e0285764.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vainer G, Huang L, Emancipator K, Nuti S, et al. Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications. PLoS One 2023;18:e0285764.
PMID: 37267266